Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

CDK1 S284-p , T285-p , S289-p , S291-p
CDK5 S291-p
ERK1 T285-p , S289-p , S377-p
mTOR T285-p , S289-p
PKCD S187-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 T285-p
PKCD S187-p
Regulatory protein:
CDK5R1 S291-p
SQSTM1 T285-p
Treatment:
angiotensin_2 S291-p , S377-p
AZD1152 S377-p
beta-amyloid_42 S291-p
BI2536 S284-p , T285-p , S289-p , S291-p , S381-p
bortezomib S377-p
EGF S291-p , S377-p
H2O2 T285-p , S289-p
hypoxia S381-p
ischemia S264-p , S289-p , S377-p
LPA T285-p , S289-p
metastatic potential S195-p , S284-p , S289-p
MG132 S284-p , T285-p , S289-p , S291-p
MG132_withdrawal S264-p
MLN4924 S377-p
MLN8237 S284-p , T285-p , S289-p , S291-p
nocodazole S195-p , S198-p , S284-p , T285-p , S289-p , S291-p , S377-p , S386-p
purvalanol S284-p , T285-p , S289-p , S291-p
R03306 S284-p , T285-p , S289-p , S291-p
RO-3306 S284-p , T285-p , S289-p , S291-p
SCH772984 S377-p
seliciclib S291-p
selumetinib S377-p , S386-p
siRNA S291-p
Su11274 Y240-p , Y247-p
tanespimycin S377-p
thymidine S284-p , T285-p , S289-p , S291-p
Torin1 T285-p , S289-p
U0126 S377-p
vemurafenib S377-p , S386-p
ZM447439 S377-p